Form 4 for BIIB Biogen
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-02 · accession 0001127602-24-012414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-02 | BIIB | Singhal Priya | Head of Development | S - Sale | $213.09 | -93 | 4,886 | -2% | -$19.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-02 | S | D | 93 | $213.09 | 4,886.48 | D | — | — | (F1) 1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024. |